Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Cardiologist details the past, present & future of drug-eluting stents | Some COVID patients may need AC therapy

News You Need to Know Today
Cardiologist details the past, present & future of drug-eluting stents | Some COVID patients may need AC therapy
Tuesday, November 23, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Q&A: Cleveland Clinic cardiologist details the past, present and future of drug-eluting stents

Amar Krishnaswamy, MD, shared his thoughts on this important technology in an exclusive interview. 

READ MORE >
thumbnail_krishnaswamy_amar_760171_1.jpg
Share on Twitter Share on Facebook Share on Linkedin

Q&A: Cleveland Clinic cardiologist details the past, present and future of drug-eluting stents

Share on Twitter Share on Facebook Share on Linkedin
thumbnail_krishnaswamy_amar_760171_1.jpg
Amar Krishnaswamy, MD, shared his thoughts on this important technology in an exclusive interview. 
READ MORE >

Some hospitalized COVID-19 patients may need anticoagulation therapy at discharge

Researchers focused on rates of venous thromboembolism among COVID-19 patients at their own health system, sharing their work in JAMA Network Open.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Some hospitalized COVID-19 patients may need anticoagulation therapy at discharge

Share on Twitter Share on Facebook Share on Linkedin
Researchers focused on rates of venous thromboembolism among COVID-19 patients at their own health system, sharing their work in JAMA Network Open.
READ MORE >

New study compares polymer and polymer-free drug-eluting stents after 3 years

The analysis included outcomes data from nearly 1,500 PCI patients. 

READ MORE >
Doctor patient
Share on Twitter Share on Facebook Share on Linkedin

New study compares polymer and polymer-free drug-eluting stents after 3 years

Share on Twitter Share on Facebook Share on Linkedin
Doctor patient
The analysis included outcomes data from nearly 1,500 PCI patients. 
READ MORE >

What we know about COVID-19 and cardiogenic shock

The full analysis was published in Circulation: Heart Failure. 

READ MORE >
sick_in_hospital.jpg
Share on Twitter Share on Facebook Share on Linkedin

What we know about COVID-19 and cardiogenic shock

Share on Twitter Share on Facebook Share on Linkedin
sick_in_hospital.jpg
The full analysis was published in Circulation: Heart Failure. 
READ MORE >

Multicenter trial to evaluate IVL treatment for peripheral lesions below the knee

The Disrupt BTK II study will include 250 patients overall. 

READ MORE >
Intravascular lithotripsy (IVL) therapy to break up calcified coronary lesions will now be reimbursed at a higher rate under new in-hospital codes the went into effect Oct. 1. Illustration of the Shockwave lithoplasty procedure using sonic waves to bust calcium without trauma.
Share on Twitter Share on Facebook Share on Linkedin

Multicenter trial to evaluate IVL treatment for peripheral lesions below the knee

Share on Twitter Share on Facebook Share on Linkedin
Intravascular lithotripsy (IVL) therapy to break up calcified coronary lesions will now be reimbursed at a higher rate under new in-hospital codes the went into effect Oct. 1. Illustration of the Shockwave lithoplasty procedure using sonic waves to bust calcium without trauma.
The Disrupt BTK II study will include 250 patients overall. 
READ MORE >

Is depression a warning sign for heart failure?

The study, published in the Journal of the American Heart Association, examined how certain symptoms related to depression might be associated with a person's risk of HFpEF and HFrEF.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Is depression a warning sign for heart failure?

Share on Twitter Share on Facebook Share on Linkedin
The study, published in the Journal of the American Heart Association, examined how certain symptoms related to depression might be associated with a person's risk of HFpEF and HFrEF.
READ MORE >

Featured Articles

Women are still experiencing COVID-related heart issues months after being diagnosed—and they may need extra help

The new analysis showed why women struggling to fully recover from COVID-19 may benefit from a targeted rehab program. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Women are still experiencing COVID-related heart issues months after being diagnosed—and they may need extra help

Share on Twitter Share on Facebook Share on Linkedin
The new analysis showed why women struggling to fully recover from COVID-19 may benefit from a targeted rehab program. 
READ MORE >

FDA delays decision on Bristol Myers Squibb’s new heart disease drug

The agency said a final decision will be made by April 2022. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FDA delays decision on Bristol Myers Squibb’s new heart disease drug

Share on Twitter Share on Facebook Share on Linkedin
The agency said a final decision will be made by April 2022. 
READ MORE >

In Other News

Fast Company lauds fast healthtech companies

The business magazine Fast Company is out with its picks for the “next big things in tech.” Of 65 companies making the overall list for 2021, the project’s inaugural year, 10 of the best are in healthcare.

READ MORE >
startup_company.jpg
Share on Twitter Share on Facebook Share on Linkedin

Fast Company lauds fast healthtech companies

Share on Twitter Share on Facebook Share on Linkedin
startup_company.jpg
The business magazine Fast Company is out with its picks for the “next big things in tech.” Of 65 companies making the overall list for 2021, the project’s inaugural year, 10 of the best are in healthcare.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

New tricuspid valve OK for US trial | Drug shows clear long-term cardiac amyloid survival | Faster PFA ablations
FDA clears new software for mitral valve repair | AI-powered CCTA assessments vs. IVUS | Safety in the cath lab
Cardiology practice pays $3.5M in data breach settlement | Key ACC trials | More screening, treatment needed for CKD
Software errors lead to major insulin pump recall | FDA approves another GLP-1 pill | Premature menopause & the heart
Hospital sues cardiology practice | Cardiologist fired for speaking out, lawsuit claims | FDA approves another GLP-1 pill
Week in Review: ‘Practice-changing’ cardiology research | Another Impella recall | FDA clears AI for pulmonary hypertension
Innovations at ACC 2026 | Lower drug costs increase medication compliance | TAVR temporary pacing lead cleared by FDA

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …13
    • Page 14
    • Page 15
    • Page 16
    • Current page 17
    • Page 18
    • Page 19
    • Page 20
    • Page 21 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme